According to Sun Pharma Advanced Research Company latest financial reports the cash on hand of SPARC is $47.98M, an increase of 3022.58% to 2022. At the end of 2022 company had $1.54M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $47.98M | 3022.58% |
2022 | $1.54M | -18.06% |
2021 | $1.88M | 77.87% |
2020 | $1.05M | -95.81% |
2019 | $25.15M | - |